SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-19-001488
Filing Date
2019-02-28
Accepted
2019-02-28 17:25:09
Documents
1
Period of Report
2019-02-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4113
  Complete submission text file 0001562180-19-001488.txt   5635
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address LISE-MEITNER-STRASSE 30 C/O PIERIS PHARMACEUTICALS, INC. FREISING-WEIHENSTEPHAN 2M 85354
Business Address
Matis Louis (Reporting) CIK: 0001650991 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 19645026